Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer

Objective: This study evaluated the cost-effectiveness of nivolumab plus ipilimumab vs. chemotherapy in the first-line setting for patients with advanced non-small-cell lung cancer (NSCLC) from the US payer perspective.Materials and methods: A Markov model wasdeveloped to evaluate the cost and effec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Xiaomin Wan (Author), Xiaohui Zeng (Author), Liubao Peng (Author), Ye Peng (Author), Qiao Liu (Author), Lidan Yi (Author), Xia Luo (Author), Qijian Deng (Author), Chongqing Tan (Author)
Formato: Livro
Publicado em: Frontiers Media S.A., 2021-08-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Área/Cota: A1234.567
Cód. Barras: 1 Disponível